Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gargi D Basu

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Oncotarget|April 23, 2021
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra<sup>®</sup>Tracey White, Szabolcs Szelinger, Janine LoBello, et al.
JCO Precision Oncology|May 11, 2022
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical CareRyan J Summers, Sharon M Castellino, Christopher C Porter, et al.
BMC Genomics|January 14, 2010
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylationDavid O Azorsa, RiLee H Robeson, Danielle Frost, et al.
Plos One|April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trialPatricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Oncotarget|April 23, 2021
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra<sup>®</sup>Tracey White, Szabolcs Szelinger, Janine LoBello, et al.
JCO Precision Oncology|May 11, 2022
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical CareRyan J Summers, Sharon M Castellino, Christopher C Porter, et al.
BMC Genomics|January 14, 2010
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylationDavid O Azorsa, RiLee H Robeson, Danielle Frost, et al.
Plos One|April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trialPatricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
Pageof 3